Tech Company Financing Transactions

Elevation Pharmaceuticals Funding Round

On 1/4/2012, Elevation Pharmaceuticals raised $30 million in Series B funding from Novo Ventures, Canaan Partners and Care Capital.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

11455 El Camino Real 460
San Diego, CA 92130
USA

Phone

858-436-1616

Website

www.elevationpharma.com

Email Address

[email protected]

Overview

Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients' lives.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Bill Gerhart

        

Chief Medical Officer

Ahmet Tutuncu

        

Chief Technical Officer

Pravin Soni

        

VP - Bus. Development

Jaisim Shah

        

Browse more venture capital transactions:

Prev: 1/4/2012: BodyShopBids venture capital transaction
Next: 1/4/2012: TraceVector venture capital transaction

Share this article

About Database of VC Transactions

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary